Market Tracker

07/03 8:27am ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.515
Delayed Data
As of Jul 02
 -0.01 / -1.90%
Today’s Change
0.34
Today|||52-Week Range
3.98
-67.81%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.53
Today’s open0.53
Day’s range0.50 - 0.54
Volume737,596
Average volume (3 months)1,942,012
Market cap$28.0M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+62.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book9.23

Competitors

 Today’s
change
Today’s
% change
--Cell Source Inc0.000.00%
ICCCImmuCell Corp+0.06+0.76%
CANFCan Fite Biopharma L...0.000.00%
ENUMEnumeral Biomedical ...-0.01-1.69%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts